SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Acro Biomedical Co., Ltd. (ACBM) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分： 13/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
0/100
Debt-to-Equity & liquidity
→ Health
估值概览 — ACBM
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$0.00 |
$0.00 |
$-43.43K |
- |
| 2017 |
$0.00 |
$510K |
$-2.25K |
-0.4% |
| 2018 |
$0.01 |
$8.01M |
$419.66K |
5.2% |
| 2019 |
$-0.01 |
$193.54K |
$-371.6K |
-192% |
| 2020 |
$0.00 |
$687.96K |
$-117.45K |
-17.1% |
| 2021 |
$-0.14 |
$1.2M |
$-7.7M |
-643.2% |
| 2022 |
$-0.26 |
$658.5K |
$-15.87M |
-2410.2% |
| 2023 |
$-0.15 |
$0.00 |
$-8.81M |
- |
| 2024 |
$0.00 |
$0.00 |
$-42.3K |
- |
| 2025 |
$0.00 |
$0.00 |
$-101.15K |
- |
